BURRILL & CO LLC 3
3 · diaDexus, Inc. · Filed Feb 18, 2011
Insider Transaction Report
Form 3
diaDexus, Inc.DDXS
Holdings
- 5,355,387
Common Stock
Footnotes (3)
- [F1]The securities ("Securities") constitute 5,355,387, or approximately 10.09%, of the common stock of diaDexus, Inc. (the "Company") based on the number of shares outstanding of the Company's common stock as of October 31, 2010, as reported in the Company's Form 10-Q filed with the Securities Exchange Commission on November 15, 2010.
- [F2]The Securities constitute 5,122,535 shares held directly by Burrill Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BLSCF"), and 232,852 shares held directly by Burrill Indiana Life Sciences Capital Fund, L.P., a Delaware limited partnership ("BILSCF"). BLSCF and BILSCF operate together as if they are a single fund. BLSGP, BIGP, Burrill and BLLC, as each are defined below, indirectly hold all 5,355,387 shares of the Securities.
- [F3]Burrill & Company (Life Sciences GP), LLC ("BLSGP") and Burrill & Company (Indiana GP), LLC ("BIGP") are the general partners of BLSCF and BILSCF, respectively. G. Steven Burrill ("Burrill") controls Burrill & Company LLC ("BCLLC"), which controls BLSGP and BIGP; therefore, Burrill ultimately holds the power to vote and dispose of the equity interests of both BLSGP and BIGP. BLSCF, BILSCF, BLSGP, BIGP, BCLLC, and Burrill (the "Reporting Persons") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Each Reporting Person disclaims beneficial ownership of the Securities, except to the extent of its pecuniary interest therein.